Clinical experiences with bisphosphonate-associated osteonecrosis of the jaws: analysis of 21 cases

American Journal of Otolaryngology - Head and Neck Medicine and Surgery

Volumn 30, Issue 6, 2009, Pages 390-395

  Junquera, Luis ^a   Gallego, Lorena ^a   Cuesta, Paz ^a   Pelaz, Alejandro ^a   de Vicente, Juan Carlos ^a  

^a Central University Hospital   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; PAMIDRONIC ACID; ZOLEDRONIC ACID;

ADULT; AGED; ARTICLE; BONE METASTASIS; BREAST CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; DEBRIDEMENT; FEMALE; HISTOPATHOLOGY; HUMAN; JAW OSTEONECROSIS; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROSTATE CANCER; RHEUMATOID ARTHRITIS; RISK FACTOR; TOOTH EXTRACTION;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BONE DENSITY CONSERVATION AGENTS; BONE NEOPLASMS; BREAST NEOPLASMS; DEBRIDEMENT; DIPHOSPHONATES; FEMALE; HUMANS; IMIDAZOLES; JAW DISEASES; MALE; MIDDLE AGED; MULTIPLE MYELOMA; OSTEONECROSIS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; TOOTH EXTRACTION; TREATMENT OUTCOME;

EID: 73049091609     PISSN: 01960709     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjoto.2008.07.014     Document Type: Article

References (21)

1. Merigo E., Manfredi M., Meleti M., et al. Bone necrosis of the jaws associated with bisphosphonate treatment: a report of twenty-nine cases. Acta Biomed 77 (2006) 109-117
2. Gutta R., and Louis P.J. Bisphosphonates and osteonecrosis of the jaws: science and rationale. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104 (2007) 186-193
3. Leite A.F., Figueiredo P.T., Melo N.S., et al. Bisphosphonate-associated osteonecrosis of the jaws. Report of a case and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 (2006) 14-21
4. Ruggiero S.L., Fantasia J., and Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 (2006) 433-441
5. Bagan J.V., Murillo J., Jimenez Y., et al. Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases. J Oral Pathol Med 34 (2005) 120-123
6. Marx R.E. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61 (2003) 1115-1117
7. Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, and American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 65 (2007) 369-376
8. Mavrokokki T., Cheng A., Stein B., et al. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac 65 (2007) 415-423
9. Durie B.G., Katz M., and Crowley J. Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 353 (2005) 99-102
10. Ruggiero S.L., Mehrotra B., Rosenberg T.J., et al. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62 (2004) 527-534
11. Marx R.E., Sawatari Y., Fortin M., et al. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63 (2005) 1567-1575
12. Lyles K.W., Colón-Emeric C.S., Magaziner J.S., et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357 (2007) 1799-1809
13. Dello Russo N.M., Jeffcoat M.K., Marx R.E., et al. Osteonecrosis in the jaws of patients who are using oral bisphosphonates to treat osteoporosis. Int J Oral Maxillofac Implants 22 (2007) 146-153
14. Brunski J.B. In vivo bone response to biochemical loading at the bone/dental-implant interface. Adv Dent Res 13 (1999) 99-119
15. Van den Wyngaert T., Huizing M.T., and Vermorken J.B. Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy. Ann Oncol 17 (2006) 1197-1204
16. Woo S.B., Hellstein J.W., and Kalmar J.R. Systematic review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144 (2006) 753-761
17. Magopoulos C., Karakinaris G., Telioudis Z., et al. Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals. Am J Otolaryngol 28 (2007) 158-163
18. Marx R.E., Cillo Jr. J.E., and Ulloa J.J. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 65 (2007) 2397-2410
19. Badros A., Weikel D., Salama A., et al. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol 24 (2006) 945-952
20. Rosen H.M., Moses A.C., Garber J., et al. Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy. Calcif Tissue Int 66 (2000) 100-103
21. Okuno S., Inaba M., Kitatani K., et al. Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients. Osteoporos Int 16 (2005) 501-509